PTEN and neoplasm: PTEN, which is one of the most common genetic alterations detected in PCa, presents in 10–46% of tumours, promoting tumour progression and proliferation of cells with a metastatic phenotype characterised by increased cell survival and the ability to invade and migrate to secondary sites.